http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-595631-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
filingDate 1944-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1947-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-595631-A
titleOfInvention Improvements in or relating to the preparation of piperidine derivatives
abstract Compounds having the general formula <FORM:0595631/IV/1> wherein R1 represents hydrogen or a lower alkyl, hydroxy-alkyl, or an alkoxy-alkyl radical, X represents a radical of the structure <FORM:0595631/IV/2> wherein R2 represents a lower alkyl, a lower alkoxy or a hydroxy radical and R3 represents hydrogen, a lower alkyl or lower alkoxy or a hydroxy radical, or both R2 and R3 together form a methylenedioxy group and one of the radicals Y and Z represents hydrogen and the other a radical of the structure <FORM:0595631/IV/3> wherein R4 and R5 have meanings similar to those assigned to R2 and R3, are obtained preferably by condensing a 2.4- or 2.6-dimethylpyridine with a substituted benzaldehyde of the formula <FORM:0595631/IV/4> to yield a phenethenyl pyridine intermediate in which the two phenethenyl radicals carry identical substituents. The terms "lower alkyl" and "lower alkoxy" refer to radicals containing not more than eight carbon atoms. Products carrying phenyl ethyl radicals containing different substituents are obtained by condensing 1 mol. of 2.4- or 2.6-dimethylpyridine with 1 mol. of a substituted benzaldehyde, and subjecting the separated monophenethenyl derivative to a second condensation with a benzaldehyde containing other substituents. Specifically suitable benzaldehydes are anisaldehyde, p-ethoxybenzaldehyde, m- or p-tolualdehydes, vanillin, isovanillin, piperonal or m- or p-hydroxy benzaldehydes. The phenethenyl pyridine compounds are next subjected to two alternative treatments: (a) heating with an alkyl, hydroxyalkyl, alkoxyalkyl or aralkyloxyalkyl-arylsulphonate, e.g. methyl-, ethyl-, propyl-, hydroxyethyl-, ethoxyethyl-, or benzoxyethyl p-toluenesulphonate and reducing the resultant phenethenyl pyridinium aryl sulphonate with hydrogen in the presence of a catalyst such as platinum, palladium, nickel or copper chromite; (b) hydrogenating catalytically the di-phenethenyl pyridine compound to obtain the 1-unsubstituted piperidine derivative which may then be alkylated with an alkyl halide, an oxalkyl halide or an oxalkyl halide ether. The reaction products may be converted into salts by treating a solution of the base with the equivalent proportion of an acid, e.g. nitric, hydriodic, hydrobromic, acetic, lactic, or with normal or acid salts of dibasic or tribasic acids, e.g. tartaric, sulphuric, phosphoric, gluconic, citric. Numerous examples are given.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2686784-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4569941-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2626948-A
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416011315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450136125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450723585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID561375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406954886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4989215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449935281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992

Total number of triples: 56.